Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Robert W Finberg MD

    TitleChair and Professor
    InstitutionUniversity of Massachusetts Medical School
    DepartmentMedicine
    AddressUniversity of Massachusetts Medical School
    364 Plantation Street, LRB
    Worcester MA 01605
    Phone508-856-1886
      Other Positions
      InstitutionUMMS - School of Medicine
      DepartmentMicrobiology and Physiological Systems

      InstitutionUMMS - Graduate School of Biomedical Sciences
      DepartmentImmunology and Virology

      InstitutionUMMS - Graduate School of Biomedical Sciences
      DepartmentInterdisciplinary Graduate Program

      InstitutionUMMS - Graduate School of Biomedical Sciences
      DepartmentMolecular Genetics and Microbiology

      InstitutionUMMS - Graduate School of Biomedical Sciences
      DepartmentTranslational Science

      InstitutionUMMS - Programs, Centers and Institutes
      DepartmentCancer Center

      InstitutionUMMS - Programs, Centers and Institutes
      DepartmentCenter for AIDS Research

        Overview 
        Narrative

        Academic/Clinical Background:

        Education:

        • A.B., University of Chicago, 1971
        • M.D., Albert Einstein College of Medicine, 1974
        • M.A. (Hon.), Harvard University, 1996

        Post-Graduate Training:

        • Resident, Internal Medicine, Bellevue Hospital, New York, NY, 1974-1977
        • Research Fellow in Pathology, Harvard Medical School, Boston, MA, 1977-1978
        • Research Fellow in Medicine, Harvard Medical School, Boston, MA, 1978-1979
        • Research/Clinical Fellow in Medicine, Peter Bent Brigham Hospital, Boston, MA, 1978-1979
        • Clinical Fellow in Medicine (Infectious Diseases), Peter Bent Brigham Hospital, Boston, MA, 1978-1980
        • Clinical Fellow in Medicine, Harvard Medical School, Boston, MA, 1979-1980

        Board Certification:

        • American Board of Internal Medicine, 1976
        • American Board of Internal Medicine (Infectious Diseases), 1980

        Honors and Awards:

        • Alpha Omega Alpha
        • Hartford Foundation Award

        • Scholar of the Leukemia & Lymphoma Society
        Dr Robert Finberg Chair of the Dept of Medicine

        Host-microbial interactions

        Dr. Finberg’s laboratory works on the relationships between host cell surface proteins and viruses and bacteria, and the basis of cellular activation mediated by cell surface proteins.

        1. Virus receptor proteins (and viral pathogenesis):
          Because of their well-defined genetics and spacious capsid, adenoviruses can be used to inject new genetic material into stem cells or, potentially, into tumor cells. The laboratory has defined the virus receptor protein for most adenoviruses, as well as the Coxsackie B group viruses (1,2). The use of several transgenic CAR expressing mouse strains are being studied and a CAR knock-out being created.
        2. Viral genes and the host: induction of virus specific immune responses:
          The laboratory has pioneered in defining a major role for "pattern recognition proteins" CD 14 and Toll-like receptors in viral pathogenesis andimmunity (3,4).
        3. Host cell surface proteins and the basis of cellular activation events:
          The laboratory has studied the mechanism of signal transduction by non-membrane spanning glycosylphosphatidylinositol (GPI) anchored, cell surface proteins. GPI anchored cell surface proteins are important signal transducing proteins. Recent investigations have led to the definition of the cell surface interactions between bacterial lipopolysaccharide (lps) that results in triggering the cytokine release that leads to septic shock. Experiments have focused on the definition of the role of CD14 and the Toll like receptor (TLR) proteins and their interactions in virus and bacterial induced signal transduction events (5).


        Rotation Projects

        Rotation Project Background

        Dr. Finberg's research is in the area of host-microbial interactions. He is working on defining cell surface proteins that control the host responses to bacteria and viruses. He is characterizing the role of CD14 and the Toll-like proteins which are "pattern recognition" proteins involved in the immune response to many different microbial antigens. In addition he is working out the pathway for viral entry into cells and how that pathway can be exploited for gene delivery. His work in infections has led him to investigate the association between viruses and cancer and to develop new methods for enhancing the immune responses to viruses to eliminate virus associated malignancies.

        Potential Rotation Projects

        1. Virus receptor proteins (and viral pathogenesis):
          Because of their well defined genetics and spacious capsid, adenoviruses can be used to inject new genetic material into stem cells or, potentially, into tumor cells. The laboratory has defined the virus receptor protein for most adenoviruses, as well as the Coxsackie B group viruses . The use of several transgenic CAR expressing mouse strains are being studied and a CAR knock-out being created.


        2. Viral genes and the host: induction of virus specific immune responses:
          The laboratory has demonstrated that viruses can be used as vectors to produce long-lasting immunity to defined antigens suggesting the possibility of new vaccine approaches to HIV-1 and other pathogens. In addition the laboratory has defined both viral proteins that affect cell death (and may lead to tumorigenesis) as well as cell proteins that result in viral persistence. The induction of immunity to herpesviruses (especially EBV) as a means of treating virus-associated malignancy is an ongoing project.


        3. Host cell surface proteins and the basis of cellular activation events:
          The laboratory has studied the mechanism of signal transduction by non-membrane spanning glycosylphosphatidylinositol (GPI) anchored, cell surface proteins. GPI anchored cell surface proteins are important signal transducing proteins. Recent investigations have led to the definition of the cell surface interactions between bacterial lipopolysaccharide (lps) that results in triggering the cytokine release that leads to septic shock. Recent experiments have focussed on the definition of the role of the GPI anchored protein and the Toll like receptor (TLR) proteins in virus and bacterial induced signal transduction events.


        Bibliographic 
        selected publications
        List All   |   Timeline
        1. de Oliveira RB, Wang JP, Ram S, Gazzinelli RT, Finberg RW, Golenbock DT. Increased Survival in B-Cell-Deficient Mice during Experimental Cerebral Malaria Suggests a Role for Circulating Immune Complexes. MBio. 2014; 5(2).
          View in: PubMed
        2. Foll M, Poh YP, Renzette N, Ferrer-Admetlla A, Bank C, Shim H, Malaspinas AS, Ewing G, Liu P, Wegmann D, Caffrey DR, Zeldovich KB, Bolon DN, Wang JP, Kowalik TF, Schiffer CA, Finberg RW, Jensen JD. Influenza virus drug resistance: a time-sampled population genetics perspective. PLoS Genet. 2014 Feb; 10(2):e1004185.
          View in: PubMed
        3. Renzette N, Caffrey DR, Zeldovich KB, Liu P, Gallagher GR, Aiello D, Porter AJ, Kurt-Jones EA, Bolon DN, Poh YP, Jensen JD, Schiffer CA, Kowalik TF, Finberg RW, Wang JP. Evolution of the Influenza A Virus Genome during Development of Oseltamivir Resistance In Vitro. J Virol. 2014 Jan; 88(1):272-81.
          View in: PubMed
        4. Wies E, Wang MK, Maharaj NP, Chen K, Zhou S, Finberg RW, Gack MU. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity. 2013 Mar 21; 38(3):437-49.
          View in: PubMed
        5. Vaine CA, Patel MK, Zhu J, Lee E, Finberg RW, Hayward RC, Kurt-Jones EA. Tuning innate immune activation by surface texturing of polymer microparticles: the role of shape in inflammasome activation. J Immunol. 2013 Apr 1; 190(7):3525-32.
          View in: PubMed
        6. Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD. Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor. Cell Rep. 2013 Feb 21; 3(2):371-85.
          View in: PubMed
        7. Hendricks GL, Weirich KL, Viswanathan K, Li J, Shriver ZH, Ashour J, Ploegh HL, Kurt-Jones EA, Fygenson DK, Finberg RW, Comolli JC, Wang JP. Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus. J Biol Chem. 2013 Mar 22; 288(12):8061-73.
          View in: PubMed
        8. Chung RT, Gordon FD, Curry MP, Schiano TD, Emre S, Corey K, Markmann JF, Hertl M, Pomposelli JJ, Pomfret EA, Florman S, Schilsky M, Broering TJ, Finberg RW, Szabo G, Zamore PD, Khettry U, Babcock GJ, Ambrosino DM, Leav B, Leney M, Smith HL, Molrine DC. Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study. Am J Transplant. 2013 Apr; 13(4):1047-54.
          View in: PubMed
        9. Cariello PF, Wickes BL, Sutton DA, Castlebury LA, Levitz SM, Finberg RW, Thompson EH, Daly JS. Phomopsis bougainvilleicola prepatellar bursitis in a renal transplant recipient. J Clin Microbiol. 2013 Feb; 51(2):692-5.
          View in: PubMed
        10. Morin TJ, Broering TJ, Leav BA, Blair BM, Rowley KJ, Boucher EN, Wang Y, Cheslock PS, Knauber M, Olsen DB, Ludmerer SW, Szabo G, Finberg RW, Purcell RH, Lanford RE, Ambrosino DM, Molrine DC, Babcock GJ. Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees. PLoS Pathog. 2012; 8(8):e1002895.
          View in: PubMed
        11. Zhou S, Cerny AM, Fitzgerald KA, Kurt-Jones EA, Finberg RW. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection. J Virol. 2012 Oct; 86(20):11254-65.
          View in: PubMed
        12. Young JL, Mora A, Cerny A, Czech MP, Woda B, Kurt-Jones EA, Finberg RW, Corvera S. CD14 deficiency impacts glucose homeostasis in mice through altered adrenal tone. PLoS One. 2012; 7(1):e29688.
          View in: PubMed
        13. Wang JP, Bowen GN, Zhou S, Cerny A, Zacharia A, Knipe DM, Finberg RW, Kurt-Jones EA. Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J Virol. 2012 Feb; 86(4):2273-81.
          View in: PubMed
        14. Kriesel JD, Jones BB, Matsunami N, Patel MK, St Pierre CA, Kurt-Jones EA, Finberg RW, Leppert M, Hobbs MR. C21orf91 genotypes correlate with herpes simplex labialis (cold sore) frequency: description of a cold sore susceptibility gene. J Infect Dis. 2011 Dec 1; 204(11):1654-62.
          View in: PubMed
        15. Wang JP, Lee CK, Akalin A, Finberg RW, Levitz SM. Contributions of the MyD88-dependent receptors IL-18R, IL-1R, and TLR9 to host defenses following pulmonary challenge with Cryptococcus neoformans. PLoS One. 2011; 6(10):e26232.
          View in: PubMed
        16. Shin OS, Uddin T, Citorik R, Wang JP, Della Pelle P, Kradin RL, Bingle CD, Bingle L, Camilli A, Bhuiyan TR, Shirin T, Ryan ET, Calderwood SB, Finberg RW, Qadri F, Larocque RC, Harris JB. LPLUNC1 modulates innate immune responses to Vibrio cholerae. J Infect Dis. 2011 Nov; 204(9):1349-57.
          View in: PubMed
        17. St Pierre CA, Leonard D, Corvera S, Kurt-Jones EA, Finberg RW. Antibodies to cell surface proteins redirect intracellular trafficking pathways. Exp Mol Pathol. 2011 Dec; 91(3):723-32.
          View in: PubMed
        18. St Pierre CA, Chan M, Iwakura Y, Ayers DC, Kurt-Jones EA, Finberg RW. Periprosthetic osteolysis: characterizing the innate immune response to titanium wear-particles. J Orthop Res. 2010 Nov; 28(11):1418-24.
          View in: PubMed
        19. McGinnes LW, Gravel KA, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Schmidt MR, Morrison TG. Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins. J Virol. 2011 Jan; 85(1):366-77.
          View in: PubMed
        20. Alexander JJ, Hack BK, Jacob A, Chang A, Haas M, Finberg RW, Quigg RJ. Abnormal immune complex processing and spontaneous glomerulonephritis in complement factor H-deficient mice with human complement receptor 1 on erythrocytes. J Immunol. 2010 Sep 15; 185(6):3759-67.
          View in: PubMed
        21. van Lint AL, Murawski MR, Goodbody RE, Severa M, Fitzgerald KA, Finberg RW, Knipe DM, Kurt-Jones EA. Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-kappaB signaling. J Virol. 2010 Oct; 84(20):10802-11.
          View in: PubMed
        22. Zhou S, Cerny AM, Bowen G, Chan M, Knipe DM, Kurt-Jones EA, Finberg RW. Discovery of a novel TLR2 signaling inhibitor with anti-viral activity. Antiviral Res. 2010 Sep; 87(3):295-306.
          View in: PubMed
        23. Zhou S, Cerny AM, Zacharia A, Fitzgerald KA, Kurt-Jones EA, Finberg RW. Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J Virol. 2010 Sep; 84(18):9452-62.
          View in: PubMed
        24. Spadafora C, Awandare GA, Kopydlowski KM, Czege J, Moch JK, Finberg RW, Tsokos GC, Stoute JA. Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum. PLoS Pathog. 2010; 6(6):e1000968.
          View in: PubMed
        25. Li J, Wang JP, Ghiran I, Cerny A, Szalai AJ, Briles DE, Finberg RW. Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence. Infect Immun. 2010 Jul; 78(7):3129-35.
          View in: PubMed
        26. Brown RA, Gralewski JH, Eid AJ, Knoll BM, Finberg RW, Razonable RR. R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins. Transplantation. 2010 Apr 15; 89(7):811-5.
          View in: PubMed
        27. Wang JP, Cerny A, Asher DR, Kurt-Jones EA, Bronson RT, Finberg RW. MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J Virol. 2010 Jan; 84(1):254-60.
          View in: PubMed
        28. Murawski MR, McGinnes LW, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Heaton PM, Fraire AE, Morrison TG. Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology. J Virol. 2010 Jan; 84(2):1110-23.
          View in: PubMed
        29. Broering TJ, Garrity KA, Boatright NK, Sloan SE, Sandor F, Thomas WD, Szabo G, Finberg RW, Ambrosino DM, Babcock GJ. Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus. J Virol. 2009 Dec; 83(23):12473-82.
          View in: PubMed
        30. Hong EG, Ko HJ, Cho YR, Kim HJ, Ma Z, Yu TY, Friedline RH, Kurt-Jones E, Finberg R, Fischer MA, Granger EL, Norbury CC, Hauschka SD, Philbrick WM, Lee CG, Elias JA, Kim JK. Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes. 2009 Nov; 58(11):2525-35.
          View in: PubMed
        31. Finberg RW, Wang JP. Antiviral responses: different roles for different tolls. Immunity. 2009 Feb 20; 30(2):173-5.
          View in: PubMed
        32. Sharif R, Dawra R, Wasiluk K, Phillips P, Dudeja V, Kurt-Jones E, Finberg R, Saluja A. Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice. Gut. 2009 Jun; 58(6):813-9.
          View in: PubMed
        33. Carlisle RC, Di Y, Cerny AM, Sonnen AF, Sim RB, Green NK, Subr V, Ulbrich K, Gilbert RJ, Fisher KD, Finberg RW, Seymour LW. Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood. 2009 Feb 26; 113(9):1909-18.
          View in: PubMed
        34. Seiradake E, Henaff D, Wodrich H, Billet O, Perreau M, Hippert C, Mennechet F, Schoehn G, Lortat-Jacob H, Dreja H, Ibanes S, Kalatzis V, Wang JP, Finberg RW, Cusack S, Kremer EJ. The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog. 2009 Jan; 5(1):e1000277.
          View in: PubMed
        35. Zhou S, Kurt-Jones EA, Cerny AM, Chan M, Bronson RT, Finberg RW. MyD88 intrinsically regulates CD4 T-cell responses. J Virol. 2009 Feb; 83(4):1625-34.
          View in: PubMed
        36. Murawski MR, Bowen GN, Cerny AM, Anderson LJ, Haynes LM, Tripp RA, Kurt-Jones EA, Finberg RW. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol. 2009 Feb; 83(3):1492-500.
          View in: PubMed
        37. Liu X, Fitzgerald K, Kurt-Jones E, Finberg R, Knipe DM. Herpesvirus tegument protein activates NF-kappaB signaling through the TRAF6 adaptor protein. Proc Natl Acad Sci U S A. 2008 Aug 12; 105(32):11335-9.
          View in: PubMed
        38. Wang JP, Bowen GN, Padden C, Cerny A, Finberg RW, Newburger PE, Kurt-Jones EA. Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood. 2008 Sep 1; 112(5):2028-34.
          View in: PubMed
        39. Zhou S, Halle A, Kurt-Jones EA, Cerny AM, Porpiglia E, Rogers M, Golenbock DT, Finberg RW. Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses. J Neuroimmunol. 2008 Feb; 194(1-2):70-82.
          View in: PubMed
        40. Finberg RW, Kurt-Jones EA. Tolls: you pay them on the way in and on the way out! J Infect Dis. 2007 Aug 15; 196(4):497-8.
          View in: PubMed
        41. Wang JP, Kurt-Jones EA, Finberg RW. Innate immunity to respiratory viruses. Cell Microbiol. 2007 Jul; 9(7):1641-6.
          View in: PubMed
        42. Zhou S, Kurt-Jones EA, Fitzgerald KA, Wang JP, Cerny AM, Chan M, Finberg RW. Role of MyD88 in route-dependent susceptibility to vesicular stomatitis virus infection. J Immunol. 2007 Apr 15; 178(8):5173-81.
          View in: PubMed
        43. Wang JP, Asher DR, Chan M, Kurt-Jones EA, Finberg RW. Cutting Edge: Antibody-mediated TLR7-dependent recognition of viral RNA. J Immunol. 2007 Mar 15; 178(6):3363-7.
          View in: PubMed
        44. Finberg RW, Wang JP, Kurt-Jones EA. Toll like receptors and viruses. Rev Med Virol. 2007 Jan-Feb; 17(1):35-43.
          View in: PubMed
        45. Wang JP, Liu P, Latz E, Golenbock DT, Finberg RW, Libraty DH. Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J Immunol. 2006 Nov 15; 177(10):7114-21.
          View in: PubMed
        46. Szomolanyi-Tsuda E, Liang X, Welsh RM, Kurt-Jones EA, Finberg RW. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J Virol. 2006 May; 80(9):4286-91.
          View in: PubMed
        47. Finberg RW, Kurt-Jones EA. CD14: chaperone or matchmaker? Immunity. 2006 Feb; 24(2):127-9.
          View in: PubMed
        48. Asher D, Finberg R. CAR might provide a survival signal for myocardial cells. J Cell Sci. 2005 Dec 15; 118(Pt 24):5679; author reply 5679-80.
          View in: PubMed
        49. Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW. Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol. 2005 Oct; 79(20):12658-66.
          View in: PubMed
        50. Asher DR, Cerny AM, Finberg RW. The erythrocyte viral trap: transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection. Proc Natl Acad Sci U S A. 2005 Sep 6; 102(36):12897-902.
          View in: PubMed
        51. Asher DR, Cerny AM, Weiler SR, Horner JW, Keeler ML, Neptune MA, Jones SN, Bronson RT, Depinho RA, Finberg RW. Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development. Genesis. 2005 Jun; 42(2):77-85.
          View in: PubMed
        52. Repik A, Pincus SE, Ghiran I, Nicholson-Weller A, Asher DR, Cerny AM, Casey LS, Jones SM, Jones SN, Mohamed N, Klickstein LB, Spitalny G, Finberg RW. A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1). Clin Exp Immunol. 2005 May; 140(2):230-40.
          View in: PubMed
        53. Divanovic S, Trompette A, Atabani SF, Madan R, Golenbock DT, Visintin A, Finberg RW, Tarakhovsky A, Vogel SN, Belkaid Y, Kurt-Jones EA, Karp CL. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol. 2005 Jun; 6(6):571-8.
          View in: PubMed
        54. Zhou S, Kurt-Jones EA, Mandell L, Cerny A, Chan M, Golenbock DT, Finberg RW. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur J Immunol. 2005 Mar; 35(3):822-30.
          View in: PubMed
        55. Kurt-Jones EA, Belko J, Yu C, Newburger PE, Wang J, Chan M, Knipe DM, Finberg RW. The role of toll-like receptors in herpes simplex infection in neonates. J Infect Dis. 2005 Mar 1; 191(5):746-8.
          View in: PubMed
        56. Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD, Coccia JA, Graziano RF, Srinivasan M, Lowy I, Finberg RW, Subbarao K, Vogel L, Somasundaran M, Luzuriaga K, Sullivan JL, Ambrosino DM. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J Infect Dis. 2005 Feb 15; 191(4):507-14.
          View in: PubMed
        57. Finberg RW, Knipe DM, Kurt-Jones EA. Herpes simplex virus and toll-like receptors. Viral Immunol. 2005; 18(3):457-65.
          View in: PubMed
        58. Divanovic S, Trompette A, Atabani SF, Madan R, Golenbock DT, Visintin A, Finberg RW, Tarakhovsky A, Vogel SN, Belkaid Y, Kurt-Jones EA, Karp CL. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1. J Endotoxin Res. 2005; 11(6):363-8.
          View in: PubMed
        59. Finberg RW, Kurt-Jones EA. Viruses and Toll-like receptors. Microbes Infect. 2004 Dec; 6(15):1356-60.
          View in: PubMed
        60. Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology. 2004 Nov; 127(5):1513-24.
          View in: PubMed
        61. Finberg RW, Moellering RC, Tally FP, Craig WA, Pankey GA, Dellinger EP, West MA, Joshi M, Linden PK, Rolston KV, Rotschafer JC, Rybak MJ. The importance of bactericidal drugs: future directions in infectious disease. Clin Infect Dis. 2004 Nov 1; 39(9):1314-20.
          View in: PubMed
        62. Solomon KR, Sharma P, Chan M, Morrison PT, Finberg RW. CD109 represents a novel branch of the alpha2-macroglobulin/complement gene family. Gene. 2004 Mar 3; 327(2):171-83.
          View in: PubMed
        63. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A. 2004 Feb 3; 101(5):1315-20.
          View in: PubMed
        64. Kurt-Jones EA, Sandor F, Ortiz Y, Bowen GN, Counter SL, Wang TC, Finberg RW. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity. J Endotoxin Res. 2004; 10(6):419-24.
          View in: PubMed
        65. Finberg RW, Re F, Popova L, Golenbock DT, Kurt-Jones EA. Cell activation by Toll-like receptors: role of LBP and CD14. J Endotoxin Res. 2004; 10(6):413-8.
          View in: PubMed
        66. Sandor F, Latz E, Re F, Mandell L, Repik G, Golenbock DT, Espevik T, Kurt-Jones EA, Finberg RW. Importance of extra- and intracellular domains of TLR1 and TLR2 in NFkappa B signaling. J Cell Biol. 2003 Sep 15; 162(6):1099-110.
          View in: PubMed
        67. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol. 2003 Apr; 77(8):4588-96.
          View in: PubMed
        68. Chen JW, Ghosh R, Finberg RW, Bergelson JM. Structure and chromosomal localization of the murine coxsackievirus and adenovirus receptor gene. DNA Cell Biol. 2003 Apr; 22(4):253-9.
          View in: PubMed
        69. Kurt-Jones EA, Mandell L, Whitney C, Padgett A, Gosselin K, Newburger PE, Finberg RW. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood. 2002 Sep 1; 100(5):1860-8.
          View in: PubMed
        70. Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdière M, Perfect J, Garber G, Fioritoni G, Anaissie E, Lee J. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002 Jan 24; 346(4):225-34.
          View in: PubMed
        71. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol. 2001 Nov; 75(22):10730-7.
          View in: PubMed
        72. Finberg RW. Epstein-Barr virus-specific T cells for the management of Epstein-Barr virus lymphomas. Curr Opin Oncol. 2001 Sep; 13(5):349-53.
          View in: PubMed
        73. Reimold AM, Kim J, Finberg R, Glimcher LH. Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice. Int Immunol. 2001 Feb; 13(2):241-8.
          View in: PubMed
        74. Tzianabos AO, Chandraker A, Kalka-Moll W, Stingele F, Dong VM, Finberg RW, Peach R, Sayegh MH. Bacterial pathogens induce abscess formation by CD4(+) T-cell activation via the CD28-B7-2 costimulatory pathway. Infect Immun. 2000 Dec; 68(12):6650-5.
          View in: PubMed
        75. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000 Nov; 1(5):398-401.
          View in: PubMed
        76. Berry JE, Murphy CM, Smith GA, Ranasinghe E, Finberg R, Walton J, Brown J, Navarrete C, Metcalfe P, Ouwehand WH. Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens. Br J Haematol. 2000 Sep; 110(3):735-42.
          View in: PubMed
        77. Martino TA, Petric M, Weingartl H, Bergelson JM, Opavsky MA, Richardson CD, Modlin JF, Finberg RW, Kain KC, Willis N, Gauntt CJ, Liu PP. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology. 2000 May 25; 271(1):99-108.
          View in: PubMed
        78. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, Calderwood SK. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000 Apr; 6(4):435-42.
          View in: PubMed
        79. Tzianabos AO, Finberg RW, Wang Y, Chan M, Onderdonk AB, Jennings HJ, Kasper DL. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J Biol Chem. 2000 Mar 10; 275(10):6733-40.
          View in: PubMed
        80. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, Fenton MJ, Oikawa M, Qureshi N, Monks B, Finberg RW, Ingalls RR, Golenbock DT. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest. 2000 Feb; 105(4):497-504.
          View in: PubMed
        81. Kalka-Moll WM, Tzianabos AO, Wang Y, Carey VJ, Finberg RW, Onderdonk AB, Kasper DL. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity. J Immunol. 2000 Jan 15; 164(2):719-24.
          View in: PubMed
        82. Rebel VI, Hartnett S, Denham J, Chan M, Finberg R, Sieff CA. Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells. Stem Cells. 2000; 18(3):176-82.
          View in: PubMed
        83. Kol A, Lichtman AH, Finberg RW, Libby P, Kurt-Jones EA. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol. 2000 Jan 1; 164(1):13-7.
          View in: PubMed
        84. Pearson AS, Koch PE, Atkinson N, Xiong M, Finberg RW, Roth JA, Fang B. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines. Clin Cancer Res. 1999 Dec; 5(12):4208-13.
          View in: PubMed
        85. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, Finberg RW, Carroll JD, Espevik T, Ingalls RR, Radolf JD, Golenbock DT. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem. 1999 Nov 19; 274(47):33419-25.
          View in: PubMed
        86. Mannick JB, Stamler JS, Teng E, Simpson N, Lawrence J, Jordan J, Finberg RW. Nitric oxide modulates HIV-1 replication. J Acquir Immune Defic Syndr. 1999 Sep 1; 22(1):1-9.
          View in: PubMed
        87. Finberg RW, Talcott JA. Fever and neutropenia--how to use a new treatment strategy. N Engl J Med. 1999 Jul 29; 341(5):362-3.
          View in: PubMed
        88. Tzianabos AO, Russell PR, Onderdonk AB, Gibson FC, Cywes C, Chan M, Finberg RW, Kasper DL. IL-2 mediates protection against abscess formation in an experimental model of sepsis. J Immunol. 1999 Jul 15; 163(2):893-7.
          View in: PubMed
        89. Marshall WL, Yim C, Gustafson E, Graf T, Sage DR, Hanify K, Williams L, Fingeroth J, Finberg RW. Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J Virol. 1999 Jun; 73(6):5181-5.
          View in: PubMed
        90. Santis G, Legrand V, Hong SS, Davison E, Kirby I, Imler JL, Finberg RW, Bergelson JM, Mehtali M, Boulanger P. Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR. J Gen Virol. 1999 Jun; 80 ( Pt 6):1519-27.
          View in: PubMed
        91. Marshall WL, Brinkman BM, Ambrose CM, Pesavento PA, Uglialoro AM, Teng E, Finberg RW, Browning JL, Goldfeld AE. Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha. J Immunol. 1999 May 15; 162(10):6016-23.
          View in: PubMed
        92. Walters RW, Grunst T, Bergelson JM, Finberg RW, Welsh MJ, Zabner J. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J Biol Chem. 1999 Apr 9; 274(15):10219-26.
          View in: PubMed
        93. Marshall WL, Datta R, Hanify K, Teng E, Finberg RW. U937 cells overexpressing bcl-xl are resistant to human immunodeficiency virus-1-induced apoptosis and human immunodeficiency virus-1 replication. Virology. 1999 Mar 30; 256(1):1-7.
          View in: PubMed
        94. Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med. 1999 Mar 11; 340(10):764-71.
          View in: PubMed
        95. Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J, Finberg R, Falck-Pedersen E, Crystal RG. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor. Am J Respir Cell Mol Biol. 1999 Mar; 20(3):361-70.
          View in: PubMed
        96. Brubaker JO, Li Q, Tzianabos AO, Kasper DL, Finberg RW. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro. J Immunol. 1999 Feb 15; 162(4):2235-42.
          View in: PubMed
        97. Hidaka C, Milano E, Leopold PL, Bergelson JM, Hackett NR, Finberg RW, Wickham TJ, Kovesdi I, Roelvink P, Crystal RG. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J Clin Invest. 1999 Feb; 103(4):579-87.
          View in: PubMed
        98. Heagy W, Teng E, Lopez P, Finberg RW. Enkephalin receptors and receptor-mediated signal transduction in cultured human lymphocytes. Cell Immunol. 1999 Jan 10; 191(1):34-48.
          View in: PubMed
        99. Teoh G, Chen L, Urashima M, Tai YT, Celi LA, Chen D, Chauhan D, Ogata A, Finberg RW, Webb IJ, Kufe DW, Anderson KC. Adenovirus vector-based purging of multiple myeloma cells. Blood. 1998 Dec 15; 92(12):4591-601.
          View in: PubMed
        100. Solomon KR, Kurt-Jones EA, Saladino RA, Stack AM, Dunn IF, Ferretti M, Golenbock D, Fleisher GR, Finberg RW. Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharide. J Clin Invest. 1998 Dec 1; 102(11):2019-27.
          View in: PubMed
        101. Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM, Finberg RW, Brough DE, Kovesdi I, Wickham TJ. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol. 1998 Oct; 72(10):7909-15.
          View in: PubMed
        102. Yokoe DS, Anderson J, Chambers R, Connor M, Finberg R, Hopkins C, Lichtenberg D, Marino S, McLaughlin D, O'Rourke E, Samore M, Sands K, Strymish J, Tamplin E, Vallonde N, Platt R. Simplified surveillance for nosocomial bloodstream infections. Infect Control Hosp Epidemiol. 1998 Sep; 19(9):657-60.
          View in: PubMed
        103. Solomon KR, Mallory MA, Finberg RW. Determination of the non-ionic detergent insolubility and phosphoprotein associations of glycosylphosphatidylinositol-anchored proteins expressed on T cells. Biochem J. 1998 Sep 1; 334 ( Pt 2):325-33.
          View in: PubMed
        104. Kelton JG, Smith JW, Horsewood P, Warner MN, Warkentin TE, Finberg RW, Hayward CP. ABH antigens on human platelets: expression on the glycosyl phosphatidylinositol-anchored protein CD109. J Lab Clin Med. 1998 Aug; 132(2):142-8.
          View in: PubMed
        105. Guttormsen HK, Wetzler LM, Finberg RW, Kasper DL. Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model. Infect Immun. 1998 May; 66(5):2026-32.
          View in: PubMed
        106. Frey BM, Hackett NR, Bergelson JM, Finberg R, Crystal RG, Moore MA, Rafii S. High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors. Blood. 1998 Apr 15; 91(8):2781-92.
          View in: PubMed
        107. Solomon KR, Mallory MA, Hanify KA, Finberg RW. The nature of membrane anchorage determines kinase association and detergent solubility of CD4. Biochem Biophys Res Commun. 1998 Jan 14; 242(2):423-8.
          View in: PubMed
        108. Bergelson JM, Krithivas A, Celi L, Droguett G, Horwitz MS, Wickham T, Crowell RL, Finberg RW. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol. 1998 Jan; 72(1):415-9.
          View in: PubMed
        109. Bergelson JM, Modlin JF, Wieland-Alter W, Cunningham JA, Crowell RL, Finberg RW. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis. 1997 Mar; 175(3):697-700.
          View in: PubMed
        110. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997 Feb 28; 275(5304):1320-3.
          View in: PubMed
        111. Dezube BJ, Ahlers CM, Lawrence JP, Teng EI, Silberman SL, Pardee AB, Finberg RW. Tenidap inhibits replication of the human immunodeficiency virus-1 in cultured cells. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jan 1; 14(1):13-7.
          View in: PubMed
        112. Webb IJ, Coral FS, Andersen JW, Elias AD, Finberg RW, Nadler LM, Ritz J, Anderson KC. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion. 1996 Sep; 36(9):782-8.
          View in: PubMed
        113. Brubaker JO, Thompson CM, Morrison LA, Knipe DM, Siber GR, Finberg RW. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus. J Immunol. 1996 Aug 15; 157(4):1598-604.
          View in: PubMed
        114. Solomon KR, Rudd CE, Finberg RW. The association between glycosylphosphatidylinositol-anchored proteins and heterotrimeric G protein alpha subunits in lymphocytes. Proc Natl Acad Sci U S A. 1996 Jun 11; 93(12):6053-8.
          View in: PubMed
        115. Jawahar S, Moody C, Chan M, Finberg R, Geha R, Chatila T. Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II). Clin Exp Immunol. 1996 Mar; 103(3):408-13.
          View in: PubMed
        116. Weller PF, Marshall WL, Lucey DR, Rand TH, Dvorak AM, Finberg RW. Infection, apoptosis, and killing of mature human eosinophils by human immunodeficiency virus-1. Am J Respir Cell Mol Biol. 1995 Nov; 13(5):610-20.
          View in: PubMed
        117. Solomon KR, Chan M, Finberg RW. Expression of GPI-anchored complement regulatory proteins CD55 and CD59 differentiates two subpopulations of human CD56+ CD3- lymphocytes (NK cells). Cell Immunol. 1995 Oct 15; 165(2):294-301.
          View in: PubMed
        118. Heagy W, Duca K, Finberg RW. Enkephalins stimulate leukemia cell migration and surface expression of CD9. J Clin Invest. 1995 Sep; 96(3):1366-74.
          View in: PubMed
        119. King SL, Cunningham JA, Finberg RW, Bergelson JM. Echovirus 1 interaction with the isolated VLA-2 I domain. J Virol. 1995 May; 69(5):3237-9.
          View in: PubMed
        120. Bergelson JM, Mohanty JG, Crowell RL, St John NF, Lublin DM, Finberg RW. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol. 1995 Mar; 69(3):1903-6.
          View in: PubMed
        121. Lew MA, Kehoe K, Ritz J, Antman KH, Nadler L, Kalish LA, Finberg R. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. J Clin Oncol. 1995 Jan; 13(1):239-50.
          View in: PubMed
        122. Deresiewicz RL, Woo J, Chan M, Finberg RW, Kasper DL. Mutations affecting the activity of toxic shock syndrome toxin-1. Biochemistry. 1994 Nov 1; 33(43):12844-51.
          View in: PubMed
        123. Haregewoin A, Edwin C, Hom RC, Finberg R. A 21-mer synthetic peptide of toxic shock syndrome toxin 1, TSST-1[58-78], activates T cells by binding to MHC class II and by an MHC unrestricted xenostimulatory pathway. Immunol Invest. 1994 Nov; 23(6-7):413-20.
          View in: PubMed
        124. Bergelson JM, St John NF, Kawaguchi S, Pasqualini R, Berdichevsky F, Hemler ME, Finberg RW. The I domain is essential for echovirus 1 interaction with VLA-2. Cell Adhes Commun. 1994 Oct; 2(5):455-64.
          View in: PubMed
        125. Kawaguchi S, Bergelson JM, Finberg RW, Hemler ME. Integrin alpha 2 cytoplasmic domain deletion effects: loss of adhesive activity parallels ligand-independent recruitment into focal adhesions. Mol Biol Cell. 1994 Sep; 5(9):977-88.
          View in: PubMed
        126. Haregewoin A, Solomon K, Hom RC, Soman G, Bergelson JM, Bhan AK, Finberg RW. Cellular expression of a GPI-linked T cell activation protein. Cell Immunol. 1994 Jul; 156(2):357-70.
          View in: PubMed
        127. Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci U S A. 1994 Jun 21; 91(13):6245-8.
          View in: PubMed
        128. Edelman JM, Chan BM, Uniyal S, Onodera H, Wang DZ, St John NF, Damjanovich L, Latzer DB, Finberg RW, Bergelson JM. The mouse VLA-2 homologue supports collagen and laminin adhesion but not virus binding. Cell Adhes Commun. 1994 Jun; 2(2):131-43.
          View in: PubMed
        129. Marshall WL, Mittler ES, Avery P, Lawrence JP, Finberg RW. Glycosylphosphatidylinositol-anchored CD4 supports human immunodeficiency virus type 1 replication, but not cytopathic effect, in T-cell transfectants. J Virol. 1994 Jun; 68(6):4039-42.
          View in: PubMed
        130. Deresiewicz RL, Flaxenburg JA, Chan M, Finberg RW, Kasper DL. Intracellular expression of toxic shock syndrome toxin 1 in Saccharomyces cerevisiae. Infect Immun. 1994 Jun; 62(6):2202-7.
          View in: PubMed
        131. Ambrosino DM, Wang M, Ciamarra A, Chan M, Bolon DL, Minn J, Jacobsohn DA, Finberg RW. T cells and natural killer cells regulate human IgG subclass concentrations in SCID mice. Cell Immunol. 1994 Apr 15; 155(1):134-43.
          View in: PubMed
        132. Nguyen L, Knipe DM, Finberg RW. Mechanism of virus-induced Ig subclass shifts. J Immunol. 1994 Jan 15; 152(2):478-84.
          View in: PubMed
        133. Talcott JA, Whalen A, Clark J, Rieker PP, Finberg R. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol. 1994 Jan; 12(1):107-14.
          View in: PubMed
        134. Bergelson JM, Finberg RW. Integrins as receptors for virus attachment and cell entry. Trends Microbiol. 1993 Nov; 1(8):287-8.
          View in: PubMed
        135. Bergelson JM, St John N, Kawaguchi S, Chan M, Stubdal H, Modlin J, Finberg RW. Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2. J Virol. 1993 Nov; 67(11):6847-52.
          View in: PubMed
        136. Bergelson JM, Chan BM, Finberg RW, Hemler ME. The integrin VLA-2 binds echovirus 1 and extracellular matrix ligands by different mechanisms. J Clin Invest. 1993 Jul; 92(1):232-9.
          View in: PubMed
        137. Weller PF, Rand TH, Barrett T, Elovic A, Wong DT, Finberg RW. Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol. 1993 Mar 15; 150(6):2554-62.
          View in: PubMed
        138. Heagy W, Shipp MA, Finberg RW. Opioid receptor agonists and Ca2+ modulation in human B cell lines. J Immunol. 1992 Dec 15; 149(12):4074-81.
          View in: PubMed
        139. Ambrosino DM, Bolon D, Collard H, Van Etten R, Kanchana MV, Finberg RW. Effect of Haemophilus influenzae polysaccharide outer membrane protein complex conjugate vaccine on macrophages. J Immunol. 1992 Dec 15; 149(12):3978-83.
          View in: PubMed
        140. Nguyen LH, Knipe DM, Finberg RW. Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection. J Virol. 1992 Dec; 66(12):7067-72.
          View in: PubMed
        141. Finberg RW, White W, Nicholson-Weller A. Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells. J Immunol. 1992 Sep 15; 149(6):2055-60.
          View in: PubMed
        142. Marshall WL, Diamond DC, Kowalski MM, Finberg RW. High level of surface CD4 prevents stable human immunodeficiency virus infection of T-cell transfectants. J Virol. 1992 Sep; 66(9):5492-9.
          View in: PubMed
        143. Bergelson JM, Shepley MP, Chan BM, Hemler ME, Finberg RW. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science. 1992 Mar 27; 255(5052):1718-20.
          View in: PubMed
        144. Finberg RW, Newburger JW, Mikati MA, Heller AH, Burns JC. Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood. J Pediatr. 1992 Mar; 120(3):376-80.
          View in: PubMed
        145. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol. 1992 Feb; 10(2):316-22.
          View in: PubMed
        146. Haregewoin A, Hom RC, Soman G, Finberg RW. Murine T cell hybridoma-derived products regulate the growth of skeletal muscle myoblasts. Lymphokine Cytokine Res. 1991 Oct; 10(5):391-6.
          View in: PubMed
        147. Robertson MJ, Socinski MA, Soiffer RJ, Finberg RW, Wilson C, Anderson KC, Bosserman L, Sang DN, Salkin IF, Ritz J. Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant. 1991 Aug; 8(2):143-5.
          View in: PubMed
        148. Finberg RW, Wahl SM, Allen JB, Soman G, Strom TB, Murphy JR, Nichols JC. Selective elimination of HIV-1-infected cells with an interleukin-2 receptor-specific cytotoxin. Science. 1991 Jun 21; 252(5013):1703-5.
          View in: PubMed
        149. Heagy W, Crumpacker C, Lopez PA, Finberg RW. Inhibition of immune functions by antiviral drugs. J Clin Invest. 1991 Jun; 87(6):1916-24.
          View in: PubMed
        150. Silberman SL, Goldman SJ, Mitchell DB, Tong AT, Rosenstein Y, Diamond DC, Finberg RW, Schreiber SL, Burakoff SJ. The interaction of CD4 with HIV-1 gp120. Semin Immunol. 1991 May; 3(3):187-92.
          View in: PubMed
        151. Soman G, Haregewoin A, Hom RC, Finberg RW. Guanidine group specific ADP-ribosyltransferase in murine cells. Biochem Biophys Res Commun. 1991 Apr 15; 176(1):301-8.
          View in: PubMed
        152. Lew MA, Kehoe K, Ritz J, Antman KH, Nadler L, Takvorian T, Mayer R, Kalish L, Finberg R. Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation. Transplantation. 1991 Mar; 51(3):630-6.
          View in: PubMed
        153. Ambrosino DM, Kanchana MV, Delaney NR, Finberg RW. Human B cells secrete predominantly lambda L chains in the absence of H chain expression. J Immunol. 1991 Jan 15; 146(2):599-602.
          View in: PubMed
        154. Finberg RW. Heat-shock proteins, and gamma alpha/delta T cells. Springer Semin Immunopathol. 1991; 13(1):55-62.
          View in: PubMed
        155. Hom RC, Finberg RW, Mullaney S, Ruprecht RM. Protective cellular retroviral immunity requires both CD4+ and CD8+ immune T cells. J Virol. 1991 Jan; 65(1):220-4.
          View in: PubMed
        156. Haregewoin A, Singh B, Gupta RS, Finberg RW. A mycobacterial heat-shock protein-responsive gamma delta T cell clone also responds to the homologous human heat-shock protein: a possible link between infection and autoimmunity. J Infect Dis. 1991 Jan; 163(1):156-60.
          View in: PubMed
        157. Finberg RW, Diamond DC, Mitchell DB, Rosenstein Y, Soman G, Norman TC, Schreiber SL, Burakoff SJ. Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120. Science. 1990 Jul 20; 249(4966):287-91.
          View in: PubMed
        158. Diamond DC, Finberg R, Chaudhuri S, Sleckman BP, Burakoff SJ. Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4. Proc Natl Acad Sci U S A. 1990 Jul; 87(13):5001-5.
          View in: PubMed
        159. Ruprecht RM, Mullaney S, Bernard LD, Gama Sosa MA, Hom RC, Finberg RW. Vaccination with a live retrovirus: the nature of the protective immune response. Proc Natl Acad Sci U S A. 1990 Jul; 87(14):5558-62.
          View in: PubMed
        160. Heagy W, Laurance M, Cohen E, Finberg R. Neurohormones regulate T cell function. J Exp Med. 1990 May 1; 171(5):1625-33.
          View in: PubMed
        161. Onderdonk AB, Cisneros RL, Finberg R, Crabb JH, Kasper DL. Animal model system for studying virulence of and host response to Bacteroides fragilis. Rev Infect Dis. 1990 Jan-Feb; 12 Suppl 2:S169-77.
          View in: PubMed
        162. Crabb JH, Finberg R, Onderdonk AB, Kasper DL. T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses. Rev Infect Dis. 1990 Jan-Feb; 12 Suppl 2:S178-84.
          View in: PubMed
        163. Heagy W, Groopman J, Schindler J, Finberg R. Use of IFN-gamma in patients with AIDS. J Acquir Immune Defic Syndr. 1990; 3(6):584-90.
          View in: PubMed
        164. Heagy W, Strom TB, Kelley VE, Collela J, Crumpacker C, Williams JM, Shapiro HM, Laubenstein L, Finberg R. Recombinant human gamma interferon enhances in vitro activation of lymphocytes isolated from patients with acquired immunodeficiency syndrome. Infect Immun. 1989 Nov; 57(11):3619-28.
          View in: PubMed
        165. Hom RC, Soman G, Finberg R. Trojan horse lymphocytes: a vesicular stomatitis virus-specific T-cell clone lyses target cells by carrying virus. J Virol. 1989 Oct; 63(10):4157-64.
          View in: PubMed
        166. Onderdonk AB, Cisneros RL, Crabb JH, Finberg RW, Kasper DL. Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber. Infect Immun. 1989 Oct; 57(10):3030-7.
          View in: PubMed
        167. Haregewoin A, Soman G, Hom RC, Finberg RW. Human gamma delta+ T cells respond to mycobacterial heat-shock protein. Nature. 1989 Jul 27; 340(6231):309-12.
          View in: PubMed
        168. Finberg RW. New concepts in the interaction between T cells and bacteria. Year Immunol. 1989-1990; 6:140-51.
          View in: PubMed
        169. Hsu HW, Finberg RW. Infections associated with animal exposure in two infants. Rev Infect Dis. 1989 Jan-Feb; 11(1):108-15.
          View in: PubMed
        170. Finberg RW. Natural killer cells: function in search of a phenotype. Year Immunol. 1989; 4:193-200.
          View in: PubMed
        171. Talcott JA, Finberg R, Mayer RJ, Goldman L. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med. 1988 Dec; 148(12):2561-8.
          View in: PubMed
        172. Eder JP, Antman K, Elias A, Shea TC, Teicher B, Henner WD, Schryber SM, Holden S, Finberg R, Chritchlow J, et al. Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors. J Natl Cancer Inst. 1988 Oct 5; 80(15):1221-6.
          View in: PubMed
        173. Cohen JI, Deresiewicz RL, Finberg RW. Fever, hypotension, and pulmonary infiltrates in a young Haitian man. Rev Infect Dis. 1988 Sep-Oct; 10(5):1052-60.
          View in: PubMed
        174. Bergelson J, Finberg RW. Regulation of the T cell receptor genes: the beginnings of the evidence. Year Immunol. 1988; 3:53-61.
          View in: PubMed
        175. Crumpacker C, Heagy W, Bubley G, Monroe JE, Finberg R, Hussey S, Schnipper L, Lucey D, Lee TH, McLane MF, et al. Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation. Ann Intern Med. 1987 Nov; 107(5):664-74.
          View in: PubMed
        176. Skinner M, Ertl HC, Finberg RW. Lymphokines induce specificity degradation in virus-induced cytolytic T-cell clones. Cell Immunol. 1987 Oct 1; 109(1):159-68.
          View in: PubMed
        177. Ambrosino DM, Siber GR, Chilmonczyk BA, Jernberg JB, Finberg RW. An immunodeficiency characterized by impaired antibody responses to polysaccharides. N Engl J Med. 1987 Mar 26; 316(13):790-3.
          View in: PubMed
        178. Antman K, Eder JP, Elias A, Shea T, Peters WP, Andersen J, Schryber S, Henner WD, Finberg R, Wilmore D, et al. High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience. Cancer Treat Rep. 1987 Feb; 71(2):119-25.
          View in: PubMed
        179. Finberg RW, Ertl H. The use of antiidiotypic antibodies as vaccines against infectious agents. Crit Rev Immunol. 1987; 7(4):269-84.
          View in: PubMed
        180. Shapiro ME, Kasper DL, Zaleznik DF, Spriggs S, Onderdonk AB, Finberg RW. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. J Immunol. 1986 Jul 1; 137(1):341-6.
          View in: PubMed
        181. Skinner MA, Finberg RW, Ertl HC. Regulation of cytotoxic lymphocyte precursors. II. The effect of interleukin-2 and interferon-gamma on the apparent specificity of effector cells. Cell Immunol. 1986 Jun; 100(1):239-46.
          View in: PubMed
        182. Peters WP, Eder JP, Henner WD, Schryber S, Wilmore D, Finberg R, Schoenfeld D, Bast R, Gargone B, Antman K, et al. High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial. J Clin Oncol. 1986 May; 4(5):646-54.
          View in: PubMed
        183. Finberg RW, Ertl HC. Use of T cell-specific anti-idiotypes to immunize against viral infections. Immunol Rev. 1986 Apr; 90:129-55.
          View in: PubMed
        184. Pennington JE, Groopman JE, Small GJ, Laubenstein L, Finberg R. Effect of intravenous recombinant gamma-interferon on the respiratory burst of blood monocytes from patients with AIDS. J Infect Dis. 1986 Mar; 153(3):609-12.
          View in: PubMed
        185. Ertl HC, Skinner MA, Finberg RW. Induction of anti-viral immunity by an anti-idiotypic antibody directed to a Sendai virus specific T helper cell clone. Int Rev Immunol. 1986 Jan; 1(1):41-65.
          View in: PubMed
        186. Finberg R, Hom R. The role of T cell immunity in infection with the herpes group viruses. Year Immunol. 1986; 2:267-78.
          View in: PubMed
        187. Sharpe AH, Gaulton GN, Ertl HC, Finberg RW, McDade KK, Fields BN, Greene MI. Cell receptors for the mammalian reovirus. IV. Reovirus-specific cytolytic T cell lines that have idiotypic receptors recognize anti-idiotypic B cell hybridomas. J Immunol. 1985 Apr; 134(4):2702-6.
          View in: PubMed
        188. Groopman JE, Mayer KH, Sarngadharan MG, Ayotte D, Devico AL, Finberg R, Sliski AH, Allan JD, Gallo RC. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston. Ann Intern Med. 1985 Mar; 102(3):334-7.
          View in: PubMed
        189. Zaleznik DF, Finberg RW, Shapiro ME, Onderdonk AB, Kasper DL. A soluble suppressor T cell factor protects against experimental intraabdominal abscesses. J Clin Invest. 1985 Mar; 75(3):1023-7.
          View in: PubMed
        190. Finberg RW. New approaches to immunization against infectious agents. Use of anti-idiotypes. Year Immunol. 1985; 175-81.
          View in: PubMed
        191. Heagy W, Kelley VE, Strom TB, Mayer K, Shapiro HM, Mandel R, Finberg R. Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma. J Clin Invest. 1984 Dec; 74(6):2089-96.
          View in: PubMed
        192. Epstein RL, Finberg R, Powers ML, Weiner HL. Interaction of reovirus with cell surface receptors. IV. The reovirus type 3 receptor is expressed predominantly on murine Lyt-2,3+ and human T8+ cells. J Immunol. 1984 Sep; 133(3):1614-7.
          View in: PubMed
        193. Nadler LM, Takvorian T, Botnick L, Bast RC, Finberg R, Hellman S, Canellos GP, Schlossman SF. Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma. Lancet. 1984 Aug 25; 2(8400):427-31.
          View in: PubMed
        194. Ertl HC, Homans E, Tournas S, Finberg RW. Sendai virus-specific T cell clones. V. Induction of a virus-specific response by antiidiotypic antibodies directed against a T helper cell clone. J Exp Med. 1984 Jun 1; 159(6):1778-83.
          View in: PubMed
        195. Ertl HC, Finberg RW. Sendai virus-specific T-cell clones: induction of cytolytic T cells by an anti-idiotypic antibody directed against a helper T-cell clone. Proc Natl Acad Sci U S A. 1984 May; 81(9):2850-4.
          View in: PubMed
        196. Ertl HC, Finberg RW. Characteristics and functions of Sendai virus-specific T-cell clones. J Virol. 1984 May; 50(2):425-31.
          View in: PubMed
        197. Onderdonk AB, Shapiro ME, Finberg RW, Zaleznik DF, Kasper DL. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis. Rev Infect Dis. 1984 Mar-Apr; 6 Suppl 1:S91-5.
          View in: PubMed
        198. Letvin NL, Hunt RD, Finberg R. Animal models of AIDS. Semin Oncol. 1984 Mar; 11(1):18-28.
          View in: PubMed
        199. Scott CF, Tsurufuji M, Lu CY, Finberg R, Sy MS. Comparison of antigen-specific T cell responses in autoimmune MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice. J Immunol. 1984 Feb; 132(2):633-9.
          View in: PubMed
        200. Finberg R. Recent developments in immunovirology. Surv Immunol Res. 1984; 3(2-3):233-7.
          View in: PubMed
        201. Kauffman RS, Lee S, Finberg R. Cytolytic T-cell mediated lysis of reovirus-infected cells: requirements for infectious virus, viral particles, and viral proteins in infected target cells. Virology. 1983 Dec; 131(2):265-73.
          View in: PubMed
        202. Kauffman RS, Noseworthy JH, Nepom JT, Finberg R, Fields BN, Greene MI. Cell receptors for the mammalian reovirus. II. Monoclonal anti-idiotypic antibody blocks viral binding to cells. J Immunol. 1983 Nov; 131(5):2539-41.
          View in: PubMed
        203. Wolf JL, Kauffman RS, Finberg R, Dambrauskas R, Fields BN, Trier JS. Determinants of reovirus interaction with the intestinal M cells and absorptive cells of murine intestine. Gastroenterology. 1983 Aug; 85(2):291-300.
          View in: PubMed
        204. Sy MS, Tsurufuji M, Finberg R, Benacerraf B. Effect of vesicular stomatitis virus (VSV) infection on the development and regulation of T cell-mediated immune responses. J Immunol. 1983 Jul; 131(1):30-6.
          View in: PubMed
        205. Shapiro ME, Onderdonk AB, Kasper DL, Finberg RW. Immune T cells prevent bacteroides fragilis abscesses. Curr Surg. 1983 Mar-Apr; 40(2):123-6.
          View in: PubMed
        206. Kauffman RS, Wolf JL, Finberg R, Trier JS, Fields BN. The sigma 1 protein determines the extent of spread of reovirus from the gastrointestinal tract of mice. Virology. 1983 Jan 30; 124(2):403-10.
          View in: PubMed
        207. Letvin NL, Kauffman RS, Finberg R. An adherent cell lyses virus-infected targets: characterization, activation, and fine specificity of the cytotoxic cell. J Immunol. 1982 Dec; 129(6):2396-401.
          View in: PubMed
        208. Ertl HC, Greene MI, Noseworthy JH, Fields BN, Nepom JT, Spriggs DR, Finberg RW. Identification of idiotypic receptors on reovirus-specific cytolytic T cells. Proc Natl Acad Sci U S A. 1982 Dec; 79(23):7479-83.
          View in: PubMed
        209. Ertl HC, Brown EG, Finberg RW. Sendai virus-specific T cell clones II. Induction of interferon production by Sendai virus-specific T helper cell clones. Eur J Immunol. 1982 Dec; 12(12):1051-3.
          View in: PubMed
        210. Takaoki M, Sy MS, Tominaga A, Lowy A, Tsurufuji M, Finberg R, Benacerraf B, Greene MI. I-J-restricted interactions in the generation of azobenzenearsonate-specific suppressor T cells. J Exp Med. 1982 Nov 1; 156(5):1325-34.
          View in: PubMed
        211. Finberg R, Spriggs DR, Fields BN. Host immune response to reovirus: CTL recognize the major neutralization domain of the viral hemagglutinin. J Immunol. 1982 Nov; 129(5):2235-8.
          View in: PubMed
        212. Sy MS, Lee SH, Tsurufuji M, Rock KL, Benacerraf B, Finberg R. Two distinct mechanisms regulate the in vivo generation of cytotoxic T cells. J Exp Med. 1982 Sep 1; 156(3):918-23.
          View in: PubMed
        213. Whitaker RB, Kauffman RS, Che M, Finberg R. CT hybridomas: tumor cells capable of lysing virally infected target cells. J Immunol. 1982 Aug; 129(2):900-3.
          View in: PubMed
        214. Shapiro ME, Onderdonk AB, Kasper DL, Finberg RW. Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med. 1982 Apr 1; 155(4):1188-97.
          View in: PubMed
        215. Greene MI, Ratnofsky S, Takaoki M, Sy MS, Burakoff S, Finberg RW. Antigen-specific suppression of cytotoxic T cell responses: an idiotype-bearing factor regulates the cytotoxic T cell response to azobenzenearsonate-coupled cells. J Immunol. 1982 Mar; 128(3):1188-91.
          View in: PubMed
        216. Takaoki M, Sy MS, Whitaker B, Nepom J, Finberg R, Germain RN, Nisonoff A, Benacerraf B, Greene MI. Biologic activity of an idiotype-bearing suppressor T cell factor produced by a long-term T cell hybridoma. J Immunol. 1982 Jan; 128(1):49-53.
          View in: PubMed
        217. Finberg R, Ertl HC, Shapiro ME. Virus-specific cytolytic cells. Their in vivo function. Surv Immunol Res. 1982; 1(3):248-54.
          View in: PubMed
        218. Shapiro ME, Burakoff SJ, Benacerraf B, Finberg RW. Ir gene control of the cytotoxic T lymphocyte response to Sendai virus: H-2k mice are low responders to Sendai. J Immunol. 1981 Dec; 127(6):2571-4.
          View in: PubMed
        219. Letvin NL, Kauffman RS, Finberg R. T lymphocyte immunity to reovirus: cellular requirements for generation and role in clearance of primary infections. J Immunol. 1981 Dec; 127(6):2334-9.
          View in: PubMed
        220. Wolf JL, Rubin DH, Finberg R, Kauffman RS, Sharpe AH, Trier JS, Fields BN. Intestinal M cells: a pathway for entry of reovirus into the host. Science. 1981 Apr 24; 212(4493):471-2.
          View in: PubMed
        221. Finberg R, Weiner HL, Burakoff SJ, Fields BN. Type-specific reovirus antiserum blocks the cytotoxic T-cell-target cell interaction: evidence for the association of the viral hemagglutinin of a nonenveloped virus with the cell surface. Infect Immun. 1981 Feb; 31(2):646-9.
          View in: PubMed
        222. Finberg R, Benacerraf B. Induction, control and consequences of virus specific cytotoxic T cells. Immunol Rev. 1981; 58:157-80.
          View in: PubMed
        223. Finberg R, Cantor H, Benacerraf B, Burakoff S. The origins of alloreactivity: differentiation of prekiller cells to viral infection results in alloreactive cytolytic T lymphocytes. J Immunol. 1980 Apr; 124(4):1858-60.
          View in: PubMed
        224. Burakoff SJ, Reiss CS, Finberg R, Mescher MF. Cell-mediated immunity to viral glycoproteins. Rev Infect Dis. 1980 Jan-Feb; 2(1):62-78.
          View in: PubMed
        225. Finberg R, Greene MI, Benacerraf B, Burakoff SJ. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. I. Evidence for antigen-specific helper T cells. J Immunol. 1979 Sep; 123(3):1205-9.
          View in: PubMed
        226. Finberg R, Burakoff SJ, Benacerraf B, Greene MI. The cytolytic T lymphocyte response to trinitrophenyl-modified syngeneic cells. II. Evidence for antigen-specific suppressor T cells. J Immunol. 1979 Sep; 123(3):1210-4.
          View in: PubMed
        227. Finberg R, Weiner HL, Fields BN, Benacerraf B, Burakoff SJ. Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proc Natl Acad Sci U S A. 1979 Jan; 76(1):442-6.
          View in: PubMed
        228. Finberg R, Mescher M, Burakoff SJ. The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins. J Exp Med. 1978 Dec 1; 148(6):1620-7.
          View in: PubMed
        229. Burakoff SJ, Finberg R, Glimcher L, Lemonnier F, Benacerraf B, Cantor H. The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigens. J Exp Med. 1978 Nov 1; 148(5):1414-22.
          View in: PubMed
        230. Finberg R, Burakoff SJ, Cantor H, Benacerraf B. Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells. Proc Natl Acad Sci U S A. 1978 Oct; 75(10):5145-9.
          View in: PubMed
        231. Finberg R, Barland P, Grayzel AI. Measurement of complement components in systemic lupus erythematosus by radial immunodiffusion. Am J Clin Pathol. 1977 Jan; 67(1):97-9.
          View in: PubMed
        For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
        Robert's Networks
        Click the "See All" links for more information and interactive visualizations!
        Concepts
        _
        Co-Authors
        _
        Similar People
        _
        Same Department
        Physical Neighbors
        _

        This is an official Page/Publication of the University of Massachusetts Worcester Campus
        Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
        Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572